Trial Profile
ASPIRE-I
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Oct 2005
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary)
- Indications Pseudomonal infections
- Focus Registrational; Therapeutic Use
- Acronyms ASPIRE-I
- 21 Oct 2005 New trial record.